MedTrace Logo

Clinical Trials in Organ Transplantation Extension Study

NCT04126746 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 501

Last updated 2025-03-21

No results posted yet for this study

Summary

The purpose of the study is to continue to follow subjects who were enrolled in the CTOT-20 CLAD Phenotypes study. Subjects will provide clinical data and complete quality of life questionnaires that will be used to determine the clinical factors associated with the development of Chronic Lung Allograft Dysfunction (CLAD) after lung transplant.

Conditions

  • Lung Transplant Failure and Rejection

Sponsors & Collaborators

Principal Investigators

  • Scott M Palmer, MD, MHS · Duke University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-17
Primary Completion
2024-08-26
Completion
2024-08-26

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04126746 on ClinicalTrials.gov